Breaking News, Collaborations & Alliances

NGM, Janssen in Diabetes Discovery Alliance

Will research protein factors using diabetes discovery platform

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

NGM Biopharmaceuticals has signed a worldwide agreement with Janssen Pharmaceuticals to discover and develop therapeutics for the potential treatment of Type 2 diabetes and other metabolic diseases. The two companies will jointly research selected protein factors discovered by NGM using its diabetes discovery platform, with the goal of advancing drug candidates that mimic the potential glucoregulatory effects of bariatric surgery on diabetes patients.    Janssen has an exclusive worldwide licens...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters